SPOTLIGHT -
What First Amendment? FDA Remains Unfazed By Off-Label Communication Issues
An FDA Memo addressing First Amendment legal issues regarding off-label use of medical products falls short of the necessary clarity, write Jamie Kendall and Alexandra Schulz.